糖生物學市場規模、佔有率、成長分析（按產品類型、按應用、按最終用戶、按地區）- 產業預測 2025-2032

2023 年全球醣生物學市場規模價值 20 億美元，預計將從 2024 年的 23 億美元成長到 2032 年的 69.8 億美元，預測期（2025-2032 年）的複合年成長率為 14.9%。

生物製藥產業正在經歷顯著成長，這得益於對個人化醫療和標靶治療的重視，這需要更深入地了解細胞和分子動力學，特別是複雜的聚醣結構。這種需求推動了製藥和生物技術公司增加研發投資，並得到了質譜和高通量聚醣分析等分析技術的進步的支持，這些技術促進了聚醣功能的研究。在政府法規的支持下，透過產學合作，我們對聚醣在疾病診斷和治療中的作用的理解正在不斷進步，特別是在癌症、感染疾病和自體免疫疾病方面。然而，聚醣固有的結構複雜性、缺乏訓練有素的人力、高成本以及新興經濟體的資源有限等挑戰阻礙了醣體學在醫療保健領域的進步和應用。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術分析

糖生物學市場規模（按產品類型和複合年成長率） (2025-2032)

• 市場概覽
• 酵素
  • 糖苷酶
  • 神經氨酸酶
  • 糖基轉移酶
  • 唾液酸轉移酶
  • 其他
• 裝置
  • 質譜儀
  • HPLC
  • MALDI-TOF
  • 陣列系統
  • 其他
• 碳水化合物
  • 寡糖
  • 多醣
  • 其他碳水化合物
• 套件
  • 聚醣標記試劑套件
  • 聚醣精製套件
  • 聚醣釋放套件
  • 其他
• 試劑
  • 糖蛋白
  • 單醣
  • 寡糖
  • 其他
• 其他

糖生物學市場規模（依應用）及複合年成長率（2025-2032）

• 市場概覽
• 診斷
• 藥物研發
• 腫瘤學
• 免疫學
• 其他用途

糖生物學市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概覽
• 製藥和生物技術公司
• 合約研究組織
• 其他最終用戶

糖生物學市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Thermo Fisher Scientific（US）
• New England Biolabs（US）
• Merck KGaA（Germany）
• Promega Corporation（US）
• Waters Corporation（US）
• Takara Bio Inc,（Japan）
• Bio-Techne（US）
• Agilent Technologies（US）
• Sumitomo Bakelite Co. Ltd.（Japan）
• Bruker Corporation（US）
• Shimadzu Corporation（Japan）
• Danaher Corporation（US）
• AMS Bio（UK）
• Ludger Ltd（UK）
• Z Biotech, LLC（US）
• Chemily Glycoscience（US）
• CD BioGlyco（US）
• GlycoDiag（France）
• Kode Biotech Limited（New Zealand）
• Glyxera GmBH（Germany）

結論和建議

Global Glycobiology Market size was valued at USD 2.0 billion in 2023 and is poised to grow from USD 2.3 billion in 2024 to USD 6.98 billion by 2032, growing at a CAGR of 14.9% during the forecast period (2025-2032).

The biopharmaceutical industry is experiencing significant growth driven by an emphasis on personalized medicine and targeted therapies, necessitating deeper insights into cellular and molecular dynamics, particularly complex carbohydrate structures. This demand is propelling increased investment in R&D among pharma and biotech firms, supported by advancements in analytical technologies like mass spectrometry and high-throughput glycan analysis facilitating glycan function research. Collaborative efforts between industry and academic institutions, alongside supportive government regulations, are advancing the understanding of glycans in disease diagnostics and treatment, particularly in cancer, infectious, and autoimmune diseases. However, challenges such as the inherent structural complexity of glycans, a shortage of trained personnel, high costs, and limited resources in developing economies hinder progress and adoption of glycomics in the healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Glycobiology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Glycobiology Market Segments Analysis

Global Glycobiology Market is segmented by Product Type, Application, End User and region. Based on Product Type, the market is segmented into Enzymes, Instruments, Carbohydrates, Kits, Reagents and Others. Based on Application, the market is segmented into Diagnostics, Drug Discovery and Development, Oncology, Immunology and Other Applications. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Contract Research Organizations and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Glycobiology Market

The global glycobiology market is significantly influenced by substantial government investments in glycomics research aimed at improving public health. For example, Australia allocated over $10 billion for scientific research innovation between 2017 and 2018, while Ireland invested $5.6 billion in 2015 to boost research activities and increase its scientific workforce from 25,000 to 40,000. Such financial commitments are crucial as they enhance research capabilities and foster advancements in the field. Consequently, these investments contribute to the steady growth of the glycobiology market, highlighting the importance of governmental support in advancing scientific research and development.

Restraints in the Global Glycobiology Market

One of the primary constraints facing the global glycobiology market is the high cost associated with glycobiology research instruments, particularly high-performance liquid chromatography (HPLC) systems and mass spectrometers. These advanced tools can cost anywhere from hundreds of thousands to millions of dollars, making them prohibitively expensive for smaller research laboratories and emerging biotechnology firms. Furthermore, the specialized reagents required for glycan analysis add to the financial burden, limiting the widespread adoption of glycomics technologies across the industry. This financial barrier hinders innovation and can stymie progress in glycobiology research and development.

Market Trends of the Global Glycobiology Market

The Global Glycobiology market is witnessing significant growth, fueled by the rising demand for personalized medicine. As the precision medicine market in Europe is projected to surge from USD 16.72 billion in 2024 to USD 38.26 billion by 2032, the focus on individualized treatment protocols strengthens the role of glycomics. By harnessing unique glycan profiles, glycobiology facilitates the creation of disease-specific drugs and therapies, thereby enhancing therapeutic outcomes. This trend reflects a broader healthcare shift towards more tailored medical solutions, positioning glycobiology at the forefront of innovative therapeutic advancements and contributing to the overall expansion of the life sciences sector globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Glycobiology Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Enzymes
  • Glycosidases
  • Neuraminidases
  • Glycosyltransferases
  • Sialyltransferases
  • Others
• Instruments
  • Mass Spectrometers
  • HPLC
  • MALDI-TOF
  • Array Systems
  • Others
• Carbohydrates
  • Oligosaccharides
  • Polysaccharides
  • Other Carbohydrates
• Kits
  • Glycan Labeling Kits
  • Glycan Purification Kits
  • Glycan Release Kits
  • Others
• Reagents
  • Glycoproteins
  • Monosaccharides
  • Oligosaccharides
  • Others
• Others

Global Glycobiology Market Size by Application & CAGR (2025-2032)

• Market Overview
• Diagnostics
• Drug Discovery and Development
• Oncology
• Immunology
• Other Applications

Global Glycobiology Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Other End Users

Global Glycobiology Market Size & CAGR (2025-2032)

• North America (Product Type, Application, End User)
  • US
  • Canada
• Europe (Product Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc, (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sumitomo Bakelite Co. Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AMS Bio (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ludger Ltd (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Z Biotech, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chemily Glycoscience (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CD BioGlyco (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlycoDiag (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kode Biotech Limited (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glyxera GmBH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations